Rheumatrex Dose Pack Alternatives Compared
Rheumatrex Dose Pack | Otezla | Upadacitinib |
|
---|
Rheumatrex Dose Pack (methotrexate) | Otezla (apremilast) | Upadacitinib |
|
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Rheumatoid Arthritis, Psoriatic Arthritis. Rheumatrex Dose Pack may also be used for purposes not listed in this medication guide. |
Prescription only
Otezla is a PDE4 inhibitor that may be used to treat adults with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet’s Disease. It may also be used to treat plaque psoriasis... View more |
Prescription only
Prescribed for Crohn's Disease, Ankylosing Spondylitis, Atopic Dermatitis, Non-Radiographic Axial Spondyloarthritis, Polyarticular Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Rheumatoid... View more |
Related suggestions Psoriatic Arthritis
|
|||||||
More about Rheumatrex Dose Pack (methotrexate) | More about Otezla (apremilast) | More about Upadacitinib | ||||||||
Ratings & Reviews | ||||||||||
Rheumatrex Dose Pack has an average rating of 2.0 out of 10 from a total of 1 ratings on Drugs.com. 0% of reviewers reported a positive effect, while 100% reported a negative effect. |
Otezla has an average rating of 5.1 out of 10 from a total of 433 ratings on Drugs.com. 35% of reviewers reported a positive effect, while 41% reported a negative effect. |
Upadacitinib has an average rating of 6.7 out of 10 from a total of 184 ratings on Drugs.com. 53% of reviewers reported a positive effect, while 22% reported a negative effect. |
||||||||
Drug Class | ||||||||||
Side Effects | ||||||||||
See also: Rheumatrex Dose Pack side effects in more detail. |
See also: Otezla side effects in more detail. |
See also: upadacitinib side effects in more detail. |
||||||||
Generic Availability | ||||||||||
N/A |
N/A |
|||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Otezla prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms Available | ||||||||||
|
|
N/A |
||||||||
Brand Names | ||||||||||
Other methotrexate brands include: Jylamvo, Methotrexate LPF Sodium, Otrexup, Rasuvo, Trexall, Xatmep |
N/A |
Rinvoq, Rinvoq LQ | ||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||
15 hours |
9 hours |
14 hours |
||||||||
CSA Schedule ** View glossary of terms | ||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | ||||||||||
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
Drug Interactions | ||||||||||
A total of 698 drugs are known to interact with Rheumatrex Dose Pack:
|
A total of 87 drugs are known to interact with Otezla:
|
A total of 579 drugs are known to interact with upadacitinib:
|
||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
|||||||||
Disease Interactions | ||||||||||
First Approval Date | ||||||||||
N/A |
March 21, 2014 |
August 16, 2019 |
||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||
N/A |
N/A |
N/A |
||||||||
More Information | ||||||||||
Patient resources | ||||||||||
Professional Resources | ||||||||||
Related Treatment Guide | ||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.